The management of small renal masses is a subject of considerable controversy. Many benign masses are surgically removed, and evidence points to the slow growth rate of conservatively managed renal tumors, leading to the suggestion that we might be overtreating small renal masses. In the second of two Viewpoints examining this issue, the authors outline arguments in favor of surveillance therapy as an appropriate management option in selected patient groups.
- Alessandro Volpe
- Michael AS Jewett
